Ropinirole |
Requip |
Ropinirole Systematic (IUPAC) name 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one Identifiers CAS number 91374-21-9 ATC code N04BC04 PubChem 5095 DrugBank APRD00302 Chemical data Formula C16H24N2O Mol. weight 260.375 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 6 hours Excretion ? Therapeutic considerations Pregnancy cat. C Legal status ℞ Prescription only Routes Oral Ropinirole (marketed as Req ...
Wikipedia - [full article]
Ropinirole News Headlines
- Tweaking The Treatment For Restless Legs
MedicalNewsToday - Wed, 27 Dec 2006 12:00 EST
- Adartrel Is First Restless Legs Syndrome Treatment To Receive A Positive Decision From The European Commission
MedicalNewsToday - Sun, 09 Apr 2006 11:00 EST
- Parkinson''s Disease - initiating patients on Ropinirole delivers long-term benefits
MedicalNewsToday - Thu, 23 Jun 2005 10:00 EST
- Long term effectiveness of ropinirole In Parkinson''s disease
MedicalNewsToday - Thu, 09 Jun 2005 10:00 EST
- Restless Leg Syndrome drug, REQUIP®, approved by FDA
MedicalNewsToday - Sat, 07 May 2005 04:00 EST

Not Signed In -


